Nexalin Technology, Inc.
$0.51
-0.0235 (-4.41%)
Latest News
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
Jun 04, 2026 10:00 AM
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO(TM) Clarity and Nexalin NeuroCare(TM) Ahead of Planned FDA Pivotal Trial
May 19, 2026 08:30 AM
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
Apr 28, 2026 09:15 AM
Nexalin Technology Advances Pivotal Clinical Trial of HALO(TM) Clarity Toward Q2 2026 Enrollment
Apr 22, 2026 09:35 AM
Nexalin Advances FDA Alzheimer's Strategy Following Landmark Leadership Meetings in the U.S. and China
Apr 15, 2026 10:00 AM
Join Nexalin's Exclusive Live Investor Webinar and Q&A Session on April 21
Apr 14, 2026 08:30 AM
Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS(TM) Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
Apr 09, 2026 07:47 AM
Nexalin Announces Pivotal HALO(TM) Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
Feb 24, 2026 08:07 AM
Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders
Feb 23, 2026 08:18 AM
Sign Up For NXL Email News Alerts
Disclosure
RedChip Companies, Inc. research reports, company profiles, and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that RedChip Companies Inc. is an investor relations firm hired by certain companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles, or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the Ontario Securities Commission (“OSC”) at www.osc.gov.on.ca.
Nexalin (NXL) is a client of RedChip Companies. NXL agreed to pay RedChip a one-time $45,000 fee for a national TV ad campaign that aired weekdays from April 1 through April 11, 2024, a one-time $40,000 fee for a national TV ad campaign aired weekdays from June 17 to June 28, 2024, a one-time $40,000 fee for a national TV ad campaign aired weekdays from October 16 to October 30, 2024, and a one-time $78,000 fee for a four-week national TV ad campaign aired weekdays from February 3 to February 28, 2025.
Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. RedChip investor awareness services include the preparation of a research profile(s), multimedia marketing, and other awareness services.